| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT04965753 | FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors | TERMINATED | PHASE1 | 2021-08-17 | 2023-12-04 | 2023-12-04 |
| NCT04891757 | FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies | ACTIVE_NOT_RECRUITING | PHASE1 | 2021-06-14 | 2027-06 | 2025-09 |
| NCT04879017 | FHD-286 in Subjects With Metastatic Uveal Melanoma | TERMINATED | PHASE1 | 2021-05-11 | 2023-11-30 | 2023-11-30 |